RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Moberg Pharma AB (publ) Stock

Moberg Pharma AB (publ) ROCE 2024

Moberg Pharma AB (publ) ROCE

-0.05

Ticker

MOB.ST

ISIN

SE0013121340

WKN

A2PUSM

In 2024, Moberg Pharma AB (publ)'s return on capital employed (ROCE) was -0.05, a 0% increase from the 0 ROCE in the previous year.

Moberg Pharma AB (publ) Aktienanalyse

What does Moberg Pharma AB (publ) do?

Moberg Pharma AB (Publ) is a Swedish pharmaceutical company that specializes in the development, manufacturing, and marketing of over-the-counter medications and medical products. The company was founded in 2011 and is headquartered in Stockholm, Sweden. It has a strong portfolio of products for pain relief, foot care, and skincare. The company's business model focuses on identifying and tapping into untapped potential in existing markets by developing innovative products that are known for their high quality and effectiveness. Moberg Pharma AB (Publ) has three main divisions: Consumer Health, Specialty Pharma, and Contract Manufacturing. Its Consumer Health division develops and markets over-the-counter health products for consumers, including pain medications, skincare, and foot care products. The Specialty Pharma division focuses on developing medications for the treatment of serious conditions such as dermatological diseases, nail fungus infections, and pain. The Contract Manufacturing division offers a wide range of services for the manufacturing and packaging of pharmaceutical products. Moberg Pharma AB (Publ) is committed to sustainability and social engagement and has launched numerous initiatives to make its practices and products environmentally friendly and sustainable. The company has also established a foundation to support research and innovation in medicine. In summary, Moberg Pharma AB (Publ) is an innovative pharmaceutical company that focuses on the development and marketing of high-quality, effective, over-the-counter medications and medical products. It has a strong product portfolio, a dedicated R&D team, and a proven sales and distribution infrastructure. It is a successful company that is focused on expanding its global presence and tapping into new markets. Moberg Pharma AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Moberg Pharma AB (publ)'s Return on Capital Employed (ROCE)

Moberg Pharma AB (publ)'s Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Moberg Pharma AB (publ)'s ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Moberg Pharma AB (publ)'s ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Moberg Pharma AB (publ)’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Moberg Pharma AB (publ) stock

What is the ROCE (Return on Capital Employed) of Moberg Pharma AB (publ) this year?

The ROCE of Moberg Pharma AB (publ) is -0.05 undefined this year.

How has the ROCE (Return on Capital Employed) of Moberg Pharma AB (publ) developed compared to the previous year?

The ROCE of Moberg Pharma AB (publ) has increased by 0% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Moberg Pharma AB (publ)?

A high Return on Capital Employed (ROCE) indicates that Moberg Pharma AB (publ) has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Moberg Pharma AB (publ)?

A low ROCE (Return on Capital Employed) can indicate that Moberg Pharma AB (publ) has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Moberg Pharma AB (publ) impact the company?

An increase in the ROCE of Moberg Pharma AB (publ) can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Moberg Pharma AB (publ) affect the company?

A decrease in ROCE of Moberg Pharma AB (publ) can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Moberg Pharma AB (publ)?

Some factors that can affect Moberg Pharma AB (publ)'s ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Moberg Pharma AB (publ) so important for investors?

The ROCE of Moberg Pharma AB (publ) is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Moberg Pharma AB (publ) take to improve the ROCE?

To improve the ROCE, Moberg Pharma AB (publ) can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Moberg Pharma AB (publ) pay?

Over the past 12 months, Moberg Pharma AB (publ) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Moberg Pharma AB (publ) is expected to pay a dividend of 0 SEK.

What is the dividend yield of Moberg Pharma AB (publ)?

The current dividend yield of Moberg Pharma AB (publ) is .

When does Moberg Pharma AB (publ) pay dividends?

Moberg Pharma AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Moberg Pharma AB (publ)?

Moberg Pharma AB (publ) paid dividends every year for the past 0 years.

What is the dividend of Moberg Pharma AB (publ)?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Moberg Pharma AB (publ) located?

Moberg Pharma AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von Moberg Pharma AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Moberg Pharma AB (publ) from 11/4/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 11/4/2024.

When did Moberg Pharma AB (publ) pay the last dividend?

The last dividend was paid out on 11/4/2024.

What was the dividend of Moberg Pharma AB (publ) in the year 2023?

In the year 2023, Moberg Pharma AB (publ) distributed 0 SEK as dividends.

In which currency does Moberg Pharma AB (publ) pay out the dividend?

The dividends of Moberg Pharma AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Moberg Pharma AB (publ)

Our stock analysis for Moberg Pharma AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Moberg Pharma AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.